Multiple endocrine neoplasia type I (MEN I) is an autosomal dominant s
yndrome comprising parathyroid, pituitary and pancreatic islet cell tu
mours. The gene for MEN I has been mapped to 11q 13 and is flanked by
markers close enough to construct haplotypes segregating with the defe
ctive gene with > 99.5% predictive accuracy. Biochemical screening for
disease manifestation can then be restricted to those carrying the ch
romosome 11 haplotype incriminated in that family. Because some patien
ts may represent new mutations or may be unaware of family history, th
e possibility of MEN I should be entertained whenever a patient with a
component of the syndrome is encountered.